Associated Papers
Targeting the ATM-TRMT10A-BRCA1 axis confers synthetic lethality to PARP inhibition in metastatic castration-resistant prostate cancer.
Yang Y et al.
Science Advances, 2025
41071892 (PubMed )
Supplement: sciadv.adw7989_tables_s1_to_s5.zip › adw7989_tables_s1_to_s5.xlsx › Table_S4.
Select a paper to view details